SINGAPORE/BEIJING (Reuters) - Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results ...
from Google Alert - health https://ift.tt/3kHbF3W
via IFTTT
0 comments:
Post a Comment